CClinicalTrials.gg
CompletedNCT05084547Updated Jan 13, 2023

Comparison of Upper Extremity Exercise Capacity and ADL Between Subjects With Bronchiectasis and Healthy Controls

An observational study in Bronchiectasis, sponsored by Hacettepe University. Completed at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-01-13.

Sponsored by Hacettepe University · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
48
Ages
18 Years and older
Sex
All
01

Study summary

Bronchiectasis is a chronic lung disease characterized by permanent dilatation and destruction, resulting from the destruction of elastic tissue and muscular components in the bronchial walls, due to infection or inflammation. The exercise tolerance, physical activity level, respiratory and peripheral muscle strength of patients with bronchiectasis are lower than those of healthy individuals. The decrease in exercise tolerance occurs while performing upper extremity activities as well as lower extremity tasks. Many studies have reported that upper extremity exercise capacity is reduced in chronic obstructive pulmonary disease (COPD), a disease similar to bronchiectasis, and that patients often experience significant dyspnea and fatigue during upper extremity tasks that are important for daily life. The mechanisms causing this situation may be neuromechanical dysfunction of the respiratory muscles (diaphragm and accessory respiratory muscles) (thoracoabdominal asynchrony) and changes in lung volume in activities involving the upper extremities. The disturbances in ventilatory mechanics in patients with COPD cause upper extremity exercise to be terminated at low workloads compared to healthy individuals. Upper extremity exercise has been defined as part of pulmonary rehabilitation. The determination of upper extremity exercise capacity may play a predictive role in maintaining and improving upper extremity and daily life activity level in patients with chronic lung disease.

Six-minute Pegboard and Ring test (6PBRT) is used to evaluate extremity exercise capacity and upper extremity function and endurance. The 6PBRT score and upper extremity daily living activities show a clear relationship in patients with COPD, and it can be used to determine and improve the performance of daily living activities in pulmonary rehabilitation programs. Glittre Activities of Daily Living (Glittre ADL test) covers activities that are necessary for daily living and commonly used activities. The Glittre ADL test produces similar cardiorespiratory responses when compared with the six-minute walk test. In this study, unsupported upper extremity exercise capacity and upper extremity function/endurance and the performance of daily living activities will be compared in participants with bronchiectasis and compared with healthy individuals.

02

Conditions studied

  • Bronchiectasis

Browse trials for

03

In context

Bronchiectasis

368 studies on the registry are indexed under Bronchiectasis; 104 are open to participants now.

This study's enrollment of 48 is below the median of 160 across 132 observational studies indexed under Bronchiectasis.

Browse Bronchiectasis studies →

Lead sponsor

Hacettepe University is the lead sponsor of 983 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Subjects with bronchiectasis and healthy controls

Inclusion criteria

  • Diagnosed with bronchiectasis and being clinically stable,
  • Being 18 years old or older,
  • Being able and willing to complete the informed consent process.

Exclusion criteria

Exclusion criteria:

  • Individuals with bronchiectasis whose clinical condition is unstable,
  • Individuals with bronchiectasis who have severe neuromuscular, musculoskeletal, and rheumatological problems,
  • Being unable to cooperate,
  • Not being willing to participate in the study

The healthy controls will be composed of individuals who volunteered for the study without any known disease. Healthy individuals who did not volunteer to participate in the study will not be included.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
48 participants (actual)
Patient registry
No

Groups and cohorts

  • Case

    Subjects with Bronchiectasis

    Other: No intervention

  • Control

    Healthy Controls

    Other: No intervention

Interventions

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Pulmonary function test - Forced vital capacity

    Pulmonary function test using a spirometer will be performed. Forced vital capacity will be recorded.

    Time frame: 1st day

  2. Pulmonary function test - Forced expiratory volume in one second

    Pulmonary function test using a spirometer will be performed. Forced expiratory volume in one second will be recorded.

    Time frame: 1st day

  3. Pulmonary function test - Forced expiratory volume in one second/Forced vital capacity

    Pulmonary function test using a spirometer will be performed. Forced expiratory volume in one second/Forced vital capacity in one second will be recorded.

    Time frame: 1st day

  4. Pulmonary function test - Peak expiratory flow

    Pulmonary function test using a spirometer will be performed. Peak expiratory flow will be recorded.

    Time frame: 1st day

  5. Pulmonary function test - Forced mid-expiratory flow (FEF25-75)

    Pulmonary function test using a spirometer will be performed. Forced mid-expiratory flow (FEF25-75) will be recorded.

    Time frame: 1st day

  6. Glittre Activities of Daily Living Test

    The test covers activities that are necessary for daily living and commonly used activities that are known to be difficult for patients with COPD.

    Time frame: 1st day

  7. Unsupported upper extremity exercise capacity

    Upper extremity exercise capacity will be evaluated using 6PBRT. During the test, the patient is asked to sit in front of a pegboard and move as many rings as possible from the two lower holes to the two upper holes, using both hands simultaneously, for six minutes. The number of rings carried during the six minutes constitutes the final score. Heart rate and oxygen saturation with pulse oximetry before and after the test, dyspnea, arm and general fatigue will be assessed.

    Time frame: 1st day

07

Study locations

1 site
  • Hacettepe University
    Ankara, 06100, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05084547
Lead sponsor
Hacettepe University
Responsible party
Aslihan Cakmak (Research Assistant, Hacettepe University) — Principal investigator
First posted
Oct 20, 2021
Start date
Jan 22, 2020
Primary completion
Dec 22, 2022
Completion
Dec 22, 2022
Last update
Jan 13, 2023

Study contacts

Aslihan Cakmak, MSc
study director · Hacettepe University
Deniz Inal-Ince, PhD
study chair · Hacettepe University
Lutfi Coplu, MD
principal investigator · Hacettepe University
Hazal Sonbahar-Ulu, PhD
principal investigator · Akdeniz University
Ebru Calik-Kutukcu, PhD
principal investigator · Hacettepe University
Naciye Vardar-Yagli, PhD
principal investigator · Hacettepe University
Melda Saglam, PhD
principal investigator · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion